Salem Investment Counselors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4K | Hold |
3,593
| – | – | ﹤0.01% | 665 |
|
|
2025
Q1 | $28.9K | Buy |
3,593
+73
| +2% | +$587 | ﹤0.01% | 662 |
|
|
2024
Q4 | $31.6K | Buy |
3,520
+3
| +0.1% | +$27 | ﹤0.01% | 659 |
|
|
2024
Q3 | $25.8K | Buy |
3,517
+8
| +0.2% | +$59 | ﹤0.01% | 701 |
|
|
2024
Q2 | $20K | Buy |
3,509
+15
| +0.4% | +$86 | ﹤0.01% | 721 |
|
|
2024
Q1 | $17.5K | Buy |
3,494
+11
| +0.3% | +$55 | ﹤0.01% | 740 |
|
|
2023
Q4 | $31.3K | Hold |
3,483
| – | – | ﹤0.01% | 632 |
|
|
2023
Q3 | $27.1K | Hold |
3,483
| – | – | ﹤0.01% | 634 |
|
|
2023
Q2 | $33.7K | Hold |
3,483
| – | – | ﹤0.01% | 592 |
|
|
2023
Q1 | $38.2K | Hold |
3,483
| – | – | ﹤0.01% | 577 |
|
|
2022
Q4 | $15K | Hold |
3,483
| – | – | ﹤0.01% | 706 |
|
|
2022
Q3 | $26K | Buy |
3,483
+108
| +3% | +$806 | ﹤0.01% | 589 |
|
|
2022
Q2 | $34K | Buy |
3,375
+20
| +0.6% | +$201 | ﹤0.01% | 570 |
|
|
2022
Q1 | $42K | Buy |
3,355
+196
| +6% | +$2.45K | ﹤0.01% | 535 |
|
|
2021
Q4 | $72K | Buy |
3,159
+68
| +2% | +$1.55K | ﹤0.01% | 507 |
|
|
2021
Q3 | $68K | Hold |
3,091
| – | – | ﹤0.01% | 450 |
|
|
2021
Q2 | $40K | Buy |
3,091
+625
| +25% | +$8.09K | ﹤0.01% | 511 |
|
|
2021
Q1 | $32K | Buy |
2,466
+416
| +20% | +$5.4K | ﹤0.01% | 516 |
|
|
2020
Q4 | $28K | Buy |
2,050
+500
| +32% | +$6.83K | ﹤0.01% | 518 |
|
|
2020
Q3 | $23K | Buy |
1,550
+800
| +107% | +$11.9K | ﹤0.01% | 475 |
|
|
2020
Q2 | $12K | Buy |
+750
| New | +$12K | ﹤0.01% | 537 |
|